comparing the efficacy of two doses of vitamin A in preterm infants

comparing the efficacy of high and low doses of vitamin A in prevention of bronchopulmonary dysplasia in preterm infants

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201505253915N17

Enrollment

100

Registered

2015-10-31

Start date

2015-05-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bronchopulmonary dysplasia. Bronchopulmonary dysplasia originating in the perinatal period

Interventions

Intervention 1: Intervention group 1: intramuscular vitamin A 1500 IU three times/ week from first week of life till 4 weeks. Intervention 2: Intervention group 2: intramuscular vitamin A 5000 IU thre

Treatment - Drugs

Intervention group 1: intramuscular vitamin A 1500 IU three times/ week from first week of life till 4 weeks.

Intervention group 2: intramuscular vitamin A 5000 IU three times/ week from first week of life till 4 weeks.

Eligibility

Sex/Gender

All

Age

No minimum to 28 Days

Inclusion criteria

Inclusion criteria: Inclusion criteria: prematurity less than 32 weeks; birth weght less than 1500 grams Exclusion criteria: major congenital anomalies; birth asphyxia death before 1 week of life; cyanotic congenital heart disease; intraventricular hemorrhage grade III or more

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Bronchopulmonary dysplasia. Timepoint: 28 days of life. Method of measurement: need for supplemental oxygen and FiO2.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Manizheh Mostafa Gharehbaghi

Tabriz University of Medical Sciences

gharehbaghimm@yahoo.com+98 41 3553 9161

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026